Lilly will provide an initial payment to complete a Phase I trial of OLX75016, which started in February 2024.
Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback